Skip to main content
logo
Hypoport SE (ETR:HYQ)
Germany flag Germany · Delayed Price · Currency is EUR
182.80
-4.80 (-2.56%)
Aug 1, 2025, 5:35 PM CET

CTI BioPharma Revenue

Hypoport SE had revenue of 159.20M EUR in the quarter ending March 31, 2025, with 19.21% growth. This brings the company's revenue in the last twelve months to 586.34M, up 9.86% year-over-year. In the year 2024, Hypoport SE had annual revenue of 560.68M with 13.52% growth.

Revenue (ttm)
586.34M
Revenue Growth
+9.86%
P/S Ratio
2.09
Revenue / Employee
264.23K
Employees
2,199
Market Cap
1.22B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024560.68M66.79M13.52%
Dec 31, 2023493.89M38.44M8.44%
Dec 31, 2022455.45M9.11M2.04%
Dec 31, 2021446.35M58.62M15.12%
Dec 31, 2020387.73M50.49M14.97%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Allianz SE109.03B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München61.84B
Deutsche Bank Aktiengesellschaft30.07B
Deutsche Börse AG7.23B
Commerzbank AG10.70B
Hannover Rück SE27.72B
Talanx AG42.09B
DWS Group GmbH & Co. KGaA4.32B
Revenue Rankings

Hypoport SE News

More News